A Study to Evaluate the Safety and Efficacy of Ipatasertib in Combination With Atezolizumab and Paclitaxel or Nab-Paclitaxel in Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Ipatasertib|DRUG: Paclitaxel|DRUG: Atezolizumab|DRUG: Nab-Paclitaxel|DRUG: AC
Sponsor: Hoffmann-La Roche